Fosun Pharma Invests $15 Million in US Early Stage Medical Fund
publication date: May 10, 2017
Shanghai Fosun Pharma will invest $15 million in Partners Innovation Fund II, a fund that will invest in medical research products originating from Partners Healthcare System of Boston. Partners Healthcare includes three major Boston-area teaching hospitals that are associated with Harvard University: Massachusetts General Hospital, Brigham and Women’s Hospital and McLean Hospital. Fosun said it was interested in PIFII as an investment, but also for potential acquisitions and China rights to promising products. More details....
Stock Symbols: (SHA: 600196; HK: 2196)
Share this with colleagues:
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.